Polymers for the sustained release of proteins and other macromolecules

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394

A modified uronic acid carbazole reaction

Bitter, T., & Muir, H. M. (1962) · Analytical Biochemistry · doi:10.1016/0003-2697(62)90095-7 · Cited by 6,259

Critical Variables in the Radioimmunoassay of Serum Insulin Using the Double Antibody Technic

Soeldner, J. S., & Slone, D. (1965) · Diabetes · doi:10.2337/diab.14.12.771 · Cited by 714

Proceedings: Tumor angiogenesis factor.

Folkman, J. (1974) · PubMed · Cited by 460

The use of silicone rubber as a carrier for prolonged drug therapy

Folkman, J., & Long, D. M. (1964) · Journal of Surgical Research · doi:10.1016/s0022-4804(64)80040-8 · Cited by 368

An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization.

Fromer, C., & Klintworth, G. K. (1975) · PubMed · Cited by 119

Radial diffusion in gel for micro determination of enzymes

Schumacher, G., & Schill, W. (1972) · Analytical Biochemistry · doi:10.1016/0003-2697(72)90165-0 · Cited by 113

Diffusion in Polymer Gel Implants

Davis, B. K. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.8.3120 · Cited by 112

Radial diffusion in gel for micro determination of enzymes

Schill, W., & Schumacher, G. (1972) · Analytical Biochemistry · doi:10.1016/0003-2697(72)90324-7 · Cited by 94

Control of diabetes with polyacrylamide implants containing insulin

Davis, B. K. (1972) · Cellular and Molecular Life Sciences · doi:10.1007/bf01928732 · Cited by 72

Cancer nanomedicine: progress, challenges and opportunities

Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076

Angiogenic factors.

Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491

Impact of Nanotechnology on Drug Delivery

Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,443

Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release

Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070

Angiogenesis: an organizing principle for drug discovery?

Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,299

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

Pérez‐Herrero, E., & Fernández‐Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,936

“Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era

Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,920

New Methods of Drug Delivery

Langer, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation

Kamaly, N., Xiao, Z., Valencia, P. M., Radovic‐Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,774

Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies

Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702

Bioresponsive materials

Lü, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,448

Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend

Kenawy, E., Bowlin, G. L., Mansfield, K. F., Layman, J. M., Simpson, D. G., Sanders, E. H., & Wnek, G. E. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00041-x · Cited by 1,312

To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288

Tumor Angiogenesis

Folkman, J. (1985) · Advances in cancer research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,068

Emerging Frontiers in Drug Delivery

Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 1,009

Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells

Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., & Vallée, B. L. (1985) · Biochemistry · doi:10.1021/bi00341a030 · Cited by 923

Development of Nanoparticles for Antimicrobial Drug Delivery

Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-W. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 904

Advances in Biomaterials for Drug Delivery

Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 890

Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres

Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., & Langer, R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015841715384 · Cited by 849

Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery

Bromberg, L. E. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00121-x · Cited by 848

Drug delivery by supramolecular design

Webber, M. J., & Langer, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00391a · Cited by 828

Activated macrophages induce vascular proliferation

Polverini, P. J., Cotran, R. S., Gimbrone, M. A., & Unanue, E. R. (1977) · Nature · doi:10.1038/269804a0 · Cited by 805

Preparation of microspheres by the solvent evaporation technique

O’Donnell, P. B., & McGinity, J. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00049-5 · Cited by 826

Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆

Farokhzad, O. C., & Langer, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 802

Biomaterials in Drug Delivery and Tissue Engineering: One Laboratory's Experience

Langer, R. (1999) · Accounts of Chemical Research · doi:10.1021/ar9800993 · Cited by 756

The origins and evolution of “controlled” drug delivery systems

Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 740

Polymeric biomaterials

Griffith, L. G. (2000) · Acta Materialia · doi:10.1016/s1359-6454(99)00299-2 · Cited by 746

How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.

Folkman, J. (1986) · PubMed · Cited by 732

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 698

Oxygen Tension Regulates the Expression of Angiogenesis Factor by Macrophages

Knighton, D. R., Hunt, T. K., Scheuenstuhl, H., Halliday, B. J., Werb, Z., & Banda, M. J. (1983) · Science · doi:10.1126/science.6612342 · Cited by 685

Present and future applications of biomaterials in controlled drug delivery systems

Langer, R., & Peppas, N. A. (1981) · Biomaterials · doi:10.1016/0142-9612(81)90059-4 · Cited by 657

Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine

Simón‐Yarza, T., Mielcarek, A., Couvreur, P., & Serre, C. (2018) · Advanced Materials · doi:10.1002/adma.201707365 · Cited by 661

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C. C., & Taylor, S. (1983) · Science · doi:10.1126/science.6192498 · Cited by 619

Inorganic nanoparticles for cancer imaging and therapy

Huang, H., Barua, S., Sharma, G., Dey, S. K., & Rege, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.004 · Cited by 642

Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)

Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 621

Selective cell transplantation using bioabsorbable artificial polymers as matrices

Vacanti, J. P., Morse, M. A., Saltzman, W. M., Domb, A. J., Pérez‐Atayde, A. R., & Langer, R. (1988) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(88)80529-3 · Cited by 613

Protamine is an inhibitor of angiogenesis

Taylor, S., & Folkman, J. (1982) · Nature · doi:10.1038/297307a0 · Cited by 580

Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors

Gagliardi, A., Giuliano, E., Eeda, V., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 616

Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery)

Bessa, P. C., Casal, M., & Reis, R. L. (2008) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.74 · Cited by 553

PLGA-Based Nanoparticles as Cancer Drug Delivery Systems

Mirakabad, F. S. T., Nejati‐Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 553

An overview of clinical and commercial impact of drug delivery systems

Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 525

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520

Targeted nanoparticles for cancer therapy

Gu, F., Karnik, R., Wang, A. Z., Alexis, F., Levy‐Nissenbaum, E., Hong, S., Langer, R., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 520

The landscape of mRNA nanomedicine

Huang, X., Kong, N., Zhang, X., Cao, Y., Langer, R., & Tao, W. (2022) · Nature Medicine · doi:10.1038/s41591-022-02061-1 · Cited by 511

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 566

Targeted therapy using nanotechnology: focus on cancer

Sechi, M., Sanna, V., & Pala, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s36654 · Cited by 509

mRNA-based cancer therapeutics

Liu, C., Shi, Q., Huang, X., Koo, S., Kong, N., & Tao, W. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00586-2 · Cited by 500

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

Jiang, W., Rk, G., DESHPANDE, M., & Schwendeman, S. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 480

Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery

Tong, R., Hemmati, H. D., Langer, R., & Kohane, D. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211888a · Cited by 478

Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation

Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 489

Angiogenesis and vasculogenesis in pregnancy

Zygmunt, M., Herr, F., Münstedt, K., Lang, U., & Liang, O. D. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00168-4 · Cited by 473

Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents

Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 468

Hydrogel-based devices for biomedical applications

Deligkaris, K., Tadele, T. S., Olthuis, W., & van den Berg, A. (2010) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2010.03.083 · Cited by 453

Breakthrough treatments for accelerated wound healing

Freedman, B. R., Hwang, C. D., Talbot, S. G., Hibler, B. P., Matoori, S., & Mooney, D. J. (2023) · Science Advances · doi:10.1126/sciadv.ade7007 · Cited by 468

Microfluidic formulation of nanoparticles for biomedical applications

Shepherd, S. J., Issadore, D., & Mitchell, M. J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120826 · Cited by 465

Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review

Langer, R., & Peppas, N. A. (1983) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/07366578308079439 · Cited by 449

Drug delivery to the central nervous system

Nance, E. A., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 442

Cancer drug delivery in the nano era: An overview and perspectives

Li, Z., Tan, S., Li, S., Shen, Q., & Wang, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5718 · Cited by 417

Targeting dendritic cells with biomaterials: developing the next generation of vaccines

Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.005 · Cited by 406

A model of angiogenesis in the mouse cornea.

Kenyon, B. M., Voest, E. E., Chen, C. C., Flynn, E. A., Folkman, J., & D’Amato, R. J. (1996) · PubMed · Cited by 403

Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier

S. Hersh, D., S. Wadajkar, A., B. Roberts, N., G. Perez, J., P. Connolly, N., Frenkel, V., A. Winkles, J., F. Woodworth, G., & J. Kim, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151221150733 · Cited by 387

Advanced Functional Materials

Taşaltın, N., Nnamchi, P. S., & Saud, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87879 · Cited by 432

Interleukin-8. A corneal factor that induces neovascularization.

Strieter, R. M., Kunkel, S. L., Elner, V. M., Mártonyi, C. L., Koch, A. E., Polverini, P. J., & Elner, V. M. (1992) · PubMed Central · Cited by 383

Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling

Patan, S. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006493130855 · Cited by 397

Nanoparticle Technologies for Cancer Therapy

Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 384

Hyaluronate in Vasculogenesis

Feinberg, R. N., & Beebe, D. C. (1983) · Science · doi:10.1126/science.6857242 · Cited by 371

Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery

Song, C., Labhasetwar, V. D., Murphy, H. S., Qu, X., Humphrey, W. R., Shebuski, R. J., & Levy, R. J. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01484-8 · Cited by 370

Hydrogels for RNA delivery

Zhong, R., Talebian, S., Mendes, B. B., Wallace, G. G., Langer, R., Conde, J., & Shi, J. (2023) · Nature Materials · doi:10.1038/s41563-023-01472-w · Cited by 391

New frontiers in nanotechnology for cancer treatment

Alexis, F., Rhee, J., Richie, J. P., Radovic‐Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.017 · Cited by 361

Elaborations on the Higuchi model for drug delivery

Paul, D. R. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.037 · Cited by 355

Drug delivery systems for programmed and on-demand release

Davoodi, P., Lee, L. Y., Xu, Q., Sunil, V., Sun, Y., Soh, S., & Wang, C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.002 · Cited by 372

Advancing the field of drug delivery

Moses, M. A., Brem, H., & Langer, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00276-9 · Cited by 344

Emerging nanopharmaceuticals

Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 342

Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion

Lieberman, D. M., Laske, D. W., Morrison, P. F., Bankiewicz, K. S., & Oldfield, E. H. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.82.6.1021 · Cited by 338

PLGA-based nanoparticles: A new paradigm in biomedical applications

Sharma, S., Parmar, A., Kori, S., & Sandhir, R. (2015) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.06.014 · Cited by 350

Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions

Berkland, C. J., Kim, K., & Pack, D. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00289-9 · Cited by 337

Nucleic acid delivery for therapeutic applications

Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113834 · Cited by 351

Localized delivery of growth factors for bone repair

Luginbuehl, V., Meinel, L., Merkle, H. P., & Gander, B. A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.004 · Cited by 336

Effects of protein dose and delivery system on BMP-mediated bone regeneration

Boerckel, J. D., Kolambkar, Y. M., Dupont, K. M., Uhrig, B. A., Phelps, E. A., Stevens, H. Y., Garcı́a, A. J., & Guldberg, R. E. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.063 · Cited by 325

Polymeric microneedles for transdermal protein delivery

Ye, Y., Yu, J., Wen, D., Kahkoska, A. R., & Gu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.015 · Cited by 331

Targeting angiogenesis in oncology, ophthalmology and beyond

Cao, Y., Langer, R., & Ferrara, N. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00671-z · Cited by 339

High-flow microinfusion: tissue penetration and pharmacodynamics

Morrison, P. F., Laske, D. W., Bobo, H., Oldfield, E. H., & Dedrick, R. L. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.266.1.r292 · Cited by 327

Progress, challenges, and future of nanomedicine

Zhang, C., Yan, L., Wang, X., Zhu, S., Chen, C., Gu, Z., & Zhao, Y. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101008 · Cited by 331

Materials and methods for delivery of biological drugs

Zelikin, A. N., Ehrhardt, C., & Healy, A. M. (2016) · Nature Chemistry · doi:10.1038/nchem.2629 · Cited by 321

Anticancer Polymeric Nanomedicines

Tong, R., & Cheng, J. (2007) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15583720701455079 · Cited by 313

Current views on calcium phosphate osteogenicity and the translation into effective bone regeneration strategies

Chai, Y. C., Carlier, A., Bolander, J., Roberts, S. J., Geris, L., Schrooten, J., Oosterwyck, H. V., & Luyten, F. P. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.07.002 · Cited by 305

pH-Responsive Polymer Nanomaterials for Tumor Therapy

Chu, S., Shi, X., Tian, Y., & Gao, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.855019 · Cited by 321

Macroscale delivery systems for molecular and cellular payloads

Kearney, C. J., & Mooney, D. J. (2013) · Nature Materials · doi:10.1038/nmat3758 · Cited by 302

Enhanced tendon healing by a tough hydrogel with an adhesive side and high drug-loading capacity

Freedman, B. R., Kuttler, A., Beckmann, N., Nam, S., Kent, D., Schuleit, M., Ramazani, F., Accart, N., Rock, A., Li, J., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00810-0 · Cited by 310

Basic fibroblast growth factor induces retinal regeneration in vivo

Park, C. M., & Hollenberg, M. J. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90089-4 · Cited by 295

Control of Angiogenesis with Synthetic Heparin Substitutes

Folkman, J., Weisz, P. B., Joullié, M. M., Li, W. W., & Ewing, W. R. (1989) · Science · doi:10.1126/science.2467380 · Cited by 289

Evolution and clinical translation of drug delivery nanomaterials

Hassan, S., Prakash, G., Bal‐Öztürk, A., Saghazadeh, S., Sohail, M. F., Seo, J., Dokmeci, M. R., Zhang, Y. S., & Khademhosseini, A. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.008 · Cited by 291

INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE

Langer, R. (1980) · Chemical Engineering Communications · doi:10.1080/00986448008912519 · Cited by 288

Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis

Kawai, K., Suzuki, S., Tabata, Y., Ikada, Y., & Nishimura, Y. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00207-0 · Cited by 285

Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging

Jung, H. N., Lee, S.-Y., Lee, S., Youn, H., & Im, H.-J. (2022) · Theranostics · doi:10.7150/thno.77259 · Cited by 282

Engineering and physical sciences in oncology: challenges and opportunities

Mitchell, M. J., Jain, R. K., & Langer, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.83 · Cited by 273

Biofunctionalized targeted nanoparticles for therapeutic applications

Wang, A. Z., Gu, F., Zhang, L., Chan, J. M., Radovic-Moreno, A., Shaikh, M. R., & Farokhzad, O. C. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1063 · Cited by 277

Angiostatic Steroids

Folkman, J., & Ingber, D. E. (1987) · Annals of Surgery · doi:10.1097/00000658-198709000-00016 · Cited by 276

Sintered Polymers for Sustained Macromolecular Drug Release

Siegel, R. A., Cohen, J. M., Brown, L. R., & Langer, R. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2745-5_22 · Cited by 4

POLYMERS FOR THE SUSTAINED RELEASE OF MACROMOLECULES: APPLICATIONS AND CONTROL OF RELEASE KINETICS

Langer, R., Rhine, W. D., Hsieh, D. S. T., & Bawa, R. S. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-074450-3.50009-7 · Cited by 23

Injectable implants for the sustained release of protein and peptide drugs

Agarwal, P., & Rupenthal, I. D. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.013 · Cited by 147

Development of polymeric implants for the long-term release of proteins

Cossé, A. (2019)

Polyanhydrides and poly(ortho esters)

(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00049-2 · Cited by 6